Xarxa de bancs de tumors de Catalunya

  • Increase font size
  • Default font size
  • Decrease font size

Hospital Universitari Arnau de Vilanova de Lleida

Correu electrònic Imprimeix PDF

Investigador Responsable: Aquesta adreça electrònica s'està protegint contra robots de correu brossa, necessiteu que el JavaScript estigui habilitat per a mostrar-la

Descripció

Nom del Banc: Biobanc IRBLleida

Centre: Institut de Recerca Biomèdica de Lleida IRB-Lleida

Institució: IRBLleida. Hospital Universitari Arnau de Vilanova (HUAV) - Universitat de Lleida.

Breu Descripció: Col.lecció de mostres de teixit congelat i parafinat

 

Personal

Nom Títol Categoria

Aquesta adreça electrònica s'està protegint contra robots de correu brossa, necessiteu que el JavaScript estigui habilitat per a mostrar-la Dr

Investigador Responsable

Aquesta adreça electrònica s'està protegint contra robots de correu brossa, necessiteu que el JavaScript estigui habilitat per a mostrar-la Dr

Bioquímica

Ingrid Prats Tècnic Tècnic de laboratori
     

Fons

 

Publicacions

  • Gene expression microarray-based assay to determine tumor site of origin in a series of metastatic tumors to the ovary and peritoneal carcinomatosis of suspected gynecologic origin. Azueta A, Maiques O, Velasco A, Santacana M, Pallares J, Novell J, Llombart-Cussac A, Gonzalez-Tallada X, Mozos A, Prat P, Pillai R, Mata M, Matias-Guiu X. Human Pathology 2013; 44(1):20-8. DOI: 10.1016/j.humpath.2012.04.018.
  • Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis. Romero-Pérez L, Castilla MA, López-García MA, Díaz-Martín J, Biscuola M, Ramiro-Fuentes S, Oliva E, Matias-Guiu X, Prat J, Cano A, Moreno-Bueno G, Palacios J. Human Pathology 2013; 44(2):244-54. DOI: 10.1016/j.humpath.2012.05.013.
  • Functional expression of voltage-gated calcium channels in human melanoma. Das A, Pushparaj C, Bahí N, Sorolla A, Herreros J, Pamplona R, Vilella R, Matias-Guiu X, Martí RM, Cantí C. Pigment Cell Melanoma Res 2012; 25(2):200-12.
  • Immunohistochemical features of post-radiation vaginal recurrences of endometrioid carcinomas of the endometrium: role for proteins involved in resistance to apoptosis and hypoxia. Santacana M, Yeramian A, Velasco A, Bergada L, Gatius S, García V, Azueta A, Palacios J, Dolcet X, Oliva E, Matias-Guiu X. Histopathology 2012; 60(3):460-71.
  • SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency. Herranz D, Maraver A, Cañamero M, Gómez-López G, Inglada-Pérez L, Robledo M, Castelblanco E, Matias-Guiu X, Serrano M. Oncogene 2012. DOI: 10.1038/onc.2012.407.
  • Importance of assessing CK19 immunostaining in core biopsies in patients subjected to sentinel node study by OSNA. Vilardell F, Novell A, Martin J, Santacana M, Velasco A, Díez-Castro MJ, Cuevas D, Panadés MJ, González S, Llombart A, Iglesias E, Matias-Guiu X. Virchows Arch 2012; 460:569-75.
  • Thyroid paraganglioma. Report of 3 cases and description of an immunohistochemical profile useful in the differential diagnosis with medullary thyroid carcinoma, based on complementary DNA array results. Castelblanco E, Gallel P, Ros S, Gatius S, Valls J, De-Cubas AA, Maliszewska A, Yebra-Pimentel MT, Menarguez J, Gamallo C, Opocher G, Robledo M, Matias-Guiu X. Human Pathology 2012; 43(7):1103-12.
  • Sprouty1 is a candidate tumor-suppressor gene in medullary thyroid carcinoma. Macià A, Gallel P, Vaquero M, Gou-Fabregas M, Santacana M, Maliszewska A, Robledo M, Gardiner JR, Basson MA, Matias-Guiu X, Encinas M. Human Pathology 2012; 31(35):3961-72.
  • Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma. Montserrat N, Mozos A, Llobet D, Dolcet X, Pons C, García de Herreros A, Matias-Guiu X, Prat J. Human Pathology 2012; 43, 632-43.
  • Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis. Rodríguez-Antona C, Pallares J, Montero-Conde C, Inglada-Pérez L, Castelblanco E, Landa I, Leskela S, Leandro-García LJ, López-Jiménez E, Letón R, Cascón A, Lerma A, Martin MC, Carralero MC, Didac M, Cruz Cigudosa J, Matias-Guiu X, Robledo M. Endocrine-Related Cancer 2010; 17:7-16.
  • The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms. Llobet D, Eritja N, Yeramian A, Pallares J, Sorolla A, Domingo M, Santacana M, Gonzalez-Tallada FJ, Matias-Guiu X, Dolcet X. European Journal of cancer 2010; 46:836-50.

Equip i tècniques

  • 1 arcon congelador -80ºC
  • 1 cuba de nitrogen
  • 1 campana de gasos

Altres